• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿挥发性组学揭示了用于无创检测透明细胞肾细胞癌的候选生物标志物组合。

Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma.

机构信息

UCIBIO/REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.

Cancer Biology & Epigenetics Group-Research Centre, Portuguese Oncology Institute of Porto (CI-IPOP), 4200-072 Porto, Portugal.

出版信息

J Proteome Res. 2021 Jun 4;20(6):3068-3077. doi: 10.1021/acs.jproteome.0c00936. Epub 2021 Apr 2.

DOI:10.1021/acs.jproteome.0c00936
PMID:33797920
Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer usually associated with asymptomatic development and risk of systemic progression. Hence, reliable molecular biomarkers of ccRCC are needed to provide early and minimally invasive detection. In this study, urinary volatilome profiling of patients diagnosed with ccRCC ( = 75), and cancer-free controls ( = 75), was performed to investigate the presence of a volatile signature characteristic of ccRCC. Volatile organic compounds (VOCs) in general, and more specifically volatile carbonyl compounds (VCCs), present in urine were extracted by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). Supervised multivariate models showed a good discriminatory power of ccRCC patients from controls in urine. Overall, 22 volatile metabolites were found significantly altered between the two groups, including aldehydes, ketones, aromatic hydrocarbons, and terpenoids. A candidate six-biomarker panel, comprising octanal, 3-methylbutanal, benzaldehyde, 2-furaldehyde, 4-heptanone, and -cresol, depicted the best performance for ccRCC detection with 83% sensitivity, 79% specificity, and 81% accuracy. Moreover, the ccRCC urinary volatilome signature suggested dysregulation of energy metabolism and overexpression of enzymes associated with carcinogenesis. These findings provide the molecular basis for the fine-tuning of gas-sensing materials for application in the development of a bioelectronic sensor.

摘要

透明细胞肾细胞癌 (ccRCC) 是最常见的肾癌类型,通常与无症状发展和全身进展风险相关。因此,需要可靠的 ccRCC 分子生物标志物来提供早期和微创检测。在这项研究中,对诊断为 ccRCC 的患者(n = 75)和无癌症对照(n = 75)的尿液挥发物谱进行了分析,以研究是否存在 ccRCC 特征性的挥发性特征。通过顶空固相微萃取与气相色谱-质谱联用(HS-SPME-GC-MS)提取尿液中一般挥发性有机化合物(VOCs),特别是挥发性羰基化合物(VCCs)。有监督的多变量模型显示,ccRCC 患者与对照组在尿液中的区分能力良好。总体而言,在两组之间发现了 22 种挥发性代谢物发生了明显变化,包括醛、酮、芳烃和萜类化合物。由辛醛、3-甲基丁醛、苯甲醛、2-糠醛、4-庚酮和间甲酚组成的候选六标志物面板,对 ccRCC 检测具有最佳性能,灵敏度为 83%,特异性为 79%,准确性为 81%。此外,ccRCC 尿液挥发物特征提示能量代谢失调和与致癌作用相关的酶过表达。这些发现为精细调整气敏材料以应用于生物电子传感器的开发提供了分子基础。

相似文献

1
Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma.尿挥发性组学揭示了用于无创检测透明细胞肾细胞癌的候选生物标志物组合。
J Proteome Res. 2021 Jun 4;20(6):3068-3077. doi: 10.1021/acs.jproteome.0c00936. Epub 2021 Apr 2.
2
Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.基于气相色谱-质谱联用技术的膀胱癌细胞系挥发性代谢组学特征。
Metabolomics. 2018 Apr 17;14(5):62. doi: 10.1007/s11306-018-1361-9.
3
GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.基于气相色谱-质谱联用代谢组学的方法用于鉴定肾细胞癌患者尿液中潜在的挥发性有机化合物生物标志物组合。
J Cell Mol Med. 2017 Sep;21(9):2092-2105. doi: 10.1111/jcmm.13132. Epub 2017 Apr 4.
4
Optimisation and validation of a HS-SPME-GC-IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits.优化和验证 HS-SPME-GC-IT/MS 方法分析人尿液中羰基挥发性化合物作为生物标志物:在区分有吸烟习惯个体的初步研究中的应用。
Talanta. 2016 Feb 1;148:486-93. doi: 10.1016/j.talanta.2015.09.070. Epub 2015 Nov 18.
5
Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach.挥发物组学揭示了用于识别肾细胞癌的潜在生物标志物:一种体外方法。
Metabolites. 2020 Apr 27;10(5):174. doi: 10.3390/metabo10050174.
6
Discrimination of Chinese vinegars based on headspace solid-phase microextraction-gas chromatography mass spectrometry of volatile compounds and multivariate analysis.基于顶空固相微萃取-气相色谱质谱联用分析挥发性成分和多元分析的中国食醋鉴别。
J Food Sci. 2011 Oct;76(8):C1125-35. doi: 10.1111/j.1750-3841.2011.02356.x.
7
Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: application in a pilot study to discriminate patients with renal cell carcinoma.固相微萃取结合气相色谱-质谱联用分析挥发性人尿代谢组学:在鉴别肾细胞癌患者的初步研究中的生物标志物发现中的应用。
Eur J Cancer. 2014 Jul;50(11):1993-2002. doi: 10.1016/j.ejca.2014.04.011. Epub 2014 May 9.
8
The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).挥发物组学——作为潜在肿瘤标志物的挥发性有机代谢物(VOM)在头颈部鳞状细胞癌(HNSCC)患者中的研究。
J Otolaryngol Head Neck Surg. 2018 Jul 3;47(1):42. doi: 10.1186/s40463-018-0288-5.
9
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer.尿液LOX-1和挥发性有机化合物组作为早期检测肾癌的有前景的工具。
Cancers (Basel). 2021 Aug 21;13(16):4213. doi: 10.3390/cancers13164213.
10
[Recent advances in the application of headspace gas chromatography-mass spectrometry].顶空气相色谱 - 质谱联用技术应用的最新进展
Se Pu. 2018 Oct 8;36(10):962-971. doi: 10.3724/SP.J.1123.2018.05013.

引用本文的文献

1
Clinicopathological-based nomogram prediction and molecular characterization of postoperative recurrence in clinical T1 clear cell renal cell carcinoma.基于临床病理的列线图预测及临床T1期透明细胞肾细胞癌术后复发的分子特征分析
BMC Surg. 2025 Jun 5;25(1):247. doi: 10.1186/s12893-025-02991-w.
2
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome.肾细胞癌肿瘤的代谢特征及其与尿液代谢组的相关性。
Metabolomics. 2025 Feb 13;21(2):26. doi: 10.1007/s11306-024-02212-0.
3
Volatile Organic Metabolites as Potential Biomarkers for Genitourinary Cancers: Review of the Applications and Detection Methods.
挥发性有机代谢物作为泌尿生殖系统癌症的潜在生物标志物:应用与检测方法综述
Metabolites. 2025 Jan 10;15(1):37. doi: 10.3390/metabo15010037.
4
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma.高通量甲基化测序揭示了用于早期检测肾细胞癌的新型生物标志物。
BMC Cancer. 2025 Jan 16;25(1):96. doi: 10.1186/s12885-024-13380-6.
5
The human volatilome meets cancer diagnostics: past, present, and future of noninvasive applications.人类挥发物组分析技术在癌症诊断中的应用:非侵入性应用的过去、现在和未来。
Metabolomics. 2024 Oct 7;20(5):113. doi: 10.1007/s11306-024-02180-5.
6
Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis.血清和尿液代谢指纹图谱可用于肾细胞癌的分类、早期诊断和预后。
Adv Sci (Weinh). 2024 Sep;11(34):e2401919. doi: 10.1002/advs.202401919. Epub 2024 Jul 8.
7
Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery-Metabolomics and Lipidomics Approaches.用于泌尿系统癌症生物标志物发现的基质辅助激光解吸/电离质谱法和表面辅助激光解吸/电离质谱法——代谢组学和脂质组学方法
Metabolites. 2024 Mar 20;14(3):173. doi: 10.3390/metabo14030173.
8
Global Urinary Volatolomics with (GC×)GC-TOF-MS.基于(GC×)GC-TOF-MS 的全球尿液挥发组学研究。
Anal Chem. 2023 Nov 28;95(47):17170-17176. doi: 10.1021/acs.analchem.3c02523. Epub 2023 Nov 15.
9
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.尿毒症毒素对慢性肾衰竭患者结肠癌发展和进展的可能影响。
Genes (Basel). 2023 Jun 13;14(6):1257. doi: 10.3390/genes14061257.
10
Insights into the Effects of Violating Statistical Assumptions for Dimensionality Reduction for Chemical "-omics" Data with Multiple Explanatory Variables.关于违反具有多个解释变量的化学“组学”数据降维统计假设的影响的见解。
ACS Omega. 2023 Jun 9;8(24):22042-22054. doi: 10.1021/acsomega.3c01613. eCollection 2023 Jun 20.